Search filters

List of works by Glenn Crater

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: a randomized placebo-controlled trial

scientific article published on 31 August 2012

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

scientific article published on 10 April 2012

Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD

scientific article published on 29 October 2011

Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients

scientific article published on 28 September 2012

Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study

scientific article

Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population.

scientific article published on 18 January 2012

Disease severity and symptoms among patients receiving monotherapy for COPD.

scientific article published in March 2011

Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes

scientific article published in October 2009

Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD

scientific article published on 22 June 2011

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD

scientific article published on 01 August 2013

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study.

scientific article published on 27 March 2013

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials.

scientific article published on December 2014

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials

scientific article published on 01 January 2020

Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD

scientific article published on 13 February 2012

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trial

scientific article

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

scientific article

Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: two randomised studies

scientific article published on 28 December 2012

Levalbuterol vs racemic albuterol: science or drug company propaganda?

scientific article published in September 2003

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.

scientific article published on September 2009

Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility

scientific article published in May 2008

Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)

scientific article published on 30 October 2019

Mobility surfaces for field-inversion gel electrophoresis of linear DNA.

scientific article

Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study

scientific article published on 02 January 2014

Prevalence of COPD among symptomatic patients in a primary care setting

Prevalence of airway obstruction assessed by lung function questionnaire

scientific article

Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy

scientific article published on 17 March 2012

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)

scientific article (publication date: February 2016)

Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial

scientific article

Safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat inhaled doses of umeclidinium in healthy subjects: two randomized studies

scientific article published on 01 July 2013

The acceleration of linear DNA during pulsed-field gel electrophoresis.

scientific article

Paulina is supported by:

About Paulina

Help